Pharmafile Logo
Pharmafocus logo
Advanced Search
AstraZeneca image

AstraZeneca ‘rejects Pfizer bid’

April 22, 2014
Research and Development, Sales and Marketing AstraZeneca, Byetta, Onglyza, Pfizer, Soriot, merger

AstraZeneca has rebuffed a £60 billion bid from Pfizer, according to media reports. Both companies have declined to comment on …

News
GSK image

GSK ‘to employ more doctors’

April 22, 2014
Medical Communications, Sales and Marketing China, Poland, gsk. doctors, shannon

GlaxoSmithKline is to employ more doctors as members of staff in a bid to ensure that the company is seen …

News
thierry_otin

Nanobiotix appoints head from Roche



April 22, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, nanobiotix, otin

France-based clinical-stage nanomedicine firm Nanobiotix has hired Thierry Otin as its head of manufacturing and supply. Prior to joining Nanobiotix, …

Appointment
Emmanuel image

Working Life: GE Healthcare’s Emmanuel Ligner

April 22, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GE Healthcare, Working Life, emmanuel linger

 How did you find your way into your current role? There have been various circumstances in my professional career that …

Feature

Biologics lift for UK

April 22, 2014
Manufacturing and Production, Sales and Marketing Cameron, UK, biologics, darlington, nbmc

Work has begun on a key new £38 million centre in Central Park, Darlington, which should increase the biologics capability …

News
screen_shot_2014-04-14_at_10

arGEN-X appoints Evotec chief executive

April 14, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Evotec, arGEN-X, lanthaler

Belgium-based clinical stage human therapeutic antibody firm arGEN-X has appointed Dr Werner Lanthaler to its supervisory board.
  Lanthaler is currently …

Appointment
Horsham image

Novartis ponders Horsham site future

April 14, 2014
Research and Development, Sales and Marketing Horsham, Novartis, Osborne, PharmaVentures, medcity, research, site

Novartis has hired specialist consultancy firm PharmaVentures to help it decide how to re-use it former Horsham site. This comes …

News
GSK image

GSK bribery controversy spreads to Poland

April 14, 2014
Medical Communications, Sales and Marketing China, FDA, GSK, Witty, bribery, cctv, iraq

Poland has become the latest country in a string of bribery claims to hit GSK as it faces legal action …

News
Low image

How can ‘innovation’ be defined?

April 14, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, NHS, UK, eric low, innovation, myeloma

Innovation has been and continues to be an important topic of discussion for a number of different stakeholders and disciplines …

Feature
Ema image

EMA to conduct major review into testosterone drugs

April 14, 2014
Research and Development, Sales and Marketing EMA, EU, Europe, heart, testosterone

The European Medicines Agency has started a review of testosterone-containing medicines as concerns grow that they may increase the risk …

News

Woodley Equipment Announces the Appointment of Claire Lever

April 11, 2014

 

Appointment
roche_logo_shadow

Roche/Novartis offices raided over anti-competitive activities

April 11, 2014
Sales and Marketing Lucentis, Novartis, Roche, SHIP Cluster, avastin, wet AMD

French competition authorities are investigating Roche and Novartis in connection with their marketing of Lucentis for wet age-related macular degeneration …

News

Pfizer’s Jonathan Emms becomes new ABPI president

April 11, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, Pfizer, jonathan emms

Jonathan Emms, UK managing director of Pfizer, has taken up his appointment as president of the ABPI, after his election …

Appointment
Jeremy Hunt

NICE to look again at Tamiflu after data saga

April 11, 2014
Medical Communications, Sales and Marketing Jeremy Hunt, Roche, Tamiflu

The UK government has asked NICE to review its guidance for Roche’s troubled pandemic flu medicine Tamiflu after a new …

News
merck_incweb

Merck gets hep C boost as competition ramps up

April 11, 2014
Research and Development, Sales and Marketing Merck, daclatasvir, hep C, sovaldi

Merck has released promising data from a trial which uses two of its investigational compounds to treat patients with hepatitis …

News
Herceptin

Herceptin faces UK competition within months

April 11, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biocon, Herceptin, Hospira, Perjeta, breast cancer

Roche’s blockbuster breast cancer drug Herceptin may soon be under threat from copycat treatments after a court in the UK …

News
Ranbaxy

Regulatory woes eclipse Sun Pharma deal

April 10, 2014
Manufacturing and Production, Sales and Marketing FDA, India, Ranbaxy, Sun Pharma

The $4 billion merger between Indian generic firms Sun Pharma and Ranbaxy has been soured by reports that the deal …

News
Tamiflu

Tamiflu stockpiling ‘unjustifiable’ and wasted £424m

April 10, 2014
Medical Communications, Research and Development, Sales and Marketing BMJ, Cochrane, Tamiflu, alltrials

Governments around the world may have squandered hundreds of millions of pounds on stockpiling Tamiflu, according to a review by …

News
haijun_dong

DIA appoints Dr Haijun Dong as MD for DIA China

April 10, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing dia

Biopharmaceutical executive Dr Haijun (Lou) Dong has been named as the new managing director for DIA China. “Dr Dong brings …

Appointment

Boehringer: ‘devil in detail’ on new drug pricing policy

April 10, 2014
Medical Communications, Sales and Marketing Boehringer, PPRS, VBP, Zinta Krumins, alltrials, vba

Zinta Krumins, the newly-appointed managing director of Boehringer Ingelheim UK and Ireland, has warned that the ‘devil is in the …

News
The Gateway to Local Adoption Series

Latest content

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026